Aspyre Clinical Test for Lung

About Biofidelity

Biofidelity is a private, commercial-stage diagnostics company addressing critical gaps in cancer genomic testing. Its proprietary technology platform underpins two main product lines: the Aspyre® Clinical Test (a Laboratory Developed Test for NSCLC) and Enspyre®, forming an end-to-end solution from early detection to treatment monitoring. The company's assays are distinguished by their simplicity, speed (2-day turnaround), and ability to work with challenging samples, positioning it to capture share in the rapidly growing precision oncology market. Biofidelity operates a CAP-accredited, CLIA-certified lab in the US and sells reagents for research use.

Therapeutic Areas

Other Non-Small Cell Lung Cancer (NSCLC) Drugs